22nd century group (xxii) supports fda policy advancements, proposed menthol ban now at omb

Buffalo, n.y., oct. 26, 2023 (globe newswire) -- 22nd century group, inc. (nasdaq: xxii ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, announced that it supports the recent move by the us food and drug administration to send final rules aimed at banning menthol in cigarettes and banning flavored cigars to the white house office of management and budget for review, a key regulatory step toward the rules becoming federal policy.
XXII Ratings Summary
XXII Quant Ranking